GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
PHARMASSET INC. (VRUS) [hlAlert]

Rating:
Outperform
VRUS
up 1,366.27 %

PHARMASSET INC. (VRUS) rated Outperform by Leerink Swann

Posted on: Monday,  Jul 28, 2008  9:25 AM ET by Leerink Swann

Leerink Swann rated Outperform PHARMASSET INC. (NASDAQ: VRUS) on 07/28/2008, when the stock price was $9.34. Since
then, PHARMASSET INC. has gained 1366.27% as of 01/17/2012's recent price of $136.95.
If you would have followed this Leerink Swann 's recommendation on VRUS, you would have gained 1366.27% of your investment in 1268 days.

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of drugs to treat viral infections. It focuses on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/28/2008 9:25 AM Buy
None
9.34
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  1,231.09 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy